| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_897a45cd85cb7bfee8371bdef7c0fbeb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09B11-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09B69-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2012-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af348943bcd0b0aa6c49531eb2f0df39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_796dffe61ebdd906312da608d5b2d56e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c50037b0cae78bf43e56005de6dd63e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccc19d80dc33bb63684b457f4ab6044a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2062d7ad0476109cf0d63f826135d3cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4304b43508a287fd16d0a457a9d1ba8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce9ad29466d5b10d3b0b525ec6df16d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fa13caede7d884e71c1af423bdc9ec8 |
| publicationDate |
2014-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2758048-A1 |
| titleOfInvention |
Mitochondria-targeted antioxidants for treatment of age-related brain disorders |
| abstract |
A method for providing to a mammal a neuroprotective effect against a brain pathology that is associated with reactive oxygen species originating from mitochondria (mROS). The method includes the step of administering to the mammal an SkQ mitochondria-targeted antioxidant in an amount effective to provide said neuroprotective effect. The SkQ mitochondria-targeted antioxidant may be administered either prophylactically or for treatment with respect to brain pathologies other than brain trauma or stroke, and may be administered for treatment of brain trauma or stroke. |
| priorityDate |
2011-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |